Legal Representation
Attorney
Jacqueline Zion
USPTO Deadlines
Next Deadline
114 days remaining
NOA E-Mailed - SOU Required
Due Date
May 30, 2026
Application History
46 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Nov 1, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Oct 31, 2025 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
| Oct 28, 2025 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
| Oct 29, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| May 2, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| May 2, 2025 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| May 1, 2025 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| May 1, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Feb 25, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Feb 25, 2025 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Nov 19, 2024 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Feb 25, 2025 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Nov 19, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| May 21, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| May 20, 2024 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| May 20, 2024 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| May 20, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Nov 1, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Oct 30, 2023 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Oct 30, 2023 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Oct 30, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| May 30, 2023 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Apr 4, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Apr 4, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Mar 15, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Feb 28, 2023 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Feb 8, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Feb 8, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Feb 7, 2023 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Jan 31, 2023 | ERSI | I | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | Loading... |
| Jan 24, 2023 | RCSC | S | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | Loading... |
| Jun 29, 2022 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Jun 29, 2022 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Jun 29, 2022 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Jun 23, 2022 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | Loading... |
| May 18, 2022 | RCSC | S | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | Loading... |
| Oct 6, 2021 | RCSC | S | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | Loading... |
| Mar 24, 2021 | RCSC | S | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | Loading... |
| Aug 25, 2020 | RCSC | S | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | Loading... |
| Aug 21, 2020 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Jan 24, 2020 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | Loading... |
| Jan 24, 2020 | GNSL | F | LETTER OF SUSPENSION E-MAILED | Loading... |
| Jan 24, 2020 | CNSL | R | SUSPENSION LETTER WRITTEN | Loading... |
| Jan 23, 2020 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Nov 19, 2019 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Nov 16, 2019 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceuticals and biopharmaceuticals for the treatment of male infertility, sexual dysfunctions and disorders, prostate enlargement, certain cancers such as breast, ovarian and prostate, gout and Familial Mediterranean Fever, and for the maintenance of sexual health; medicated pre-moistened wipes designed to prolong penile erections and warming gels for use by women as a personal lubricant
Class 010
Contraceptive Apparatus
Class 042
Product development in the field of pharmaceuticals and biopharmaceuticals for the treatment of male infertility, sexual dysfunctions and disorders, prostate enlargement, certain cancers such as breast, ovarian and prostate, gout and Familial Mediterranean Fever, and for the maintenance of sexual health
Classification
International Classes
005
010
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"HEALTHCARE"